The official twitter account, promoting the Sputnik V COVID-19 vaccine, tweeted on 20 January 2021 that Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, has filed for registration of the COVID-19 Sputnik V in the European Union and expects it to be reviewed in February 2021, Reuters news agency reported on Wednesday.
This moves the vaccine closer to a wider adoption across the globe.
The Sputnik V twitter account said that teams from the vaccine and the European Medical Agency (EMA) held a scientific review of the vaccine on 19 January 2021, adding that the EMA will take a decision on the authorisation of the vaccine based on the reviews.
RDIF's chief, Kirill Dmitriev, had said in an interview at the Reuters Next conference last week that Russia would submit a formal application to the European Union in February 2021 for approval of its Sputnik V COVID-19 vaccine.
Reportedly, the Sputnik V vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
Precision Epigenomics partners with TruDiagnostic
Illumina's GRAIL divestment plan receives EC approval
Soligenix receives orphan drug designation from FDA for active ingredient in SuVax
Candel Therapeutics granted FDA Orphan Drug Designation for CAN-2409 in pancreatic cancer treatment
Lipogems completes patient enrolment in ARISE I US FDA IDE study
Amylyx Pharmaceuticals' AMX0035 shows promising impact on Wolfram syndrome symptoms
Ondine Biomedical's Steriwave approved for use by HCA UK
Roche attains CE Mark for first companion diagnostic for HER2-low metastatic breast cancer
Cadrenal Therapeutics' tecarfarin receives US FDA Orphan Drug Designation
BioCity Biopharma's BC2027 Phase one study IND application receives US FDA approval
Seres Therapeutics completes patient enrollment for SER-155 Phase 1B trial
Syros receives Fast Track Designation from FDA for tamibarotene in AML
Ligand Pharmaceuticals announces presentation of Captisol-enabled Topiramate Injection data